(Q47806980)

English

Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Adipose tissue derived stromal stem cell therapy in murine ConA-derived hepatitis is dependent on myeloid-lineage and CD4+ T-cell suppression (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

author name string

Mami Higashimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Yoshio Sakai

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Masayuki Takamura

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Soichiro Usui

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Alessandro Nasti

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Keiko Yoshida

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Akihiro Seki

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Takuya Komura

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Masao Honda

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Takashi Wada

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Kengo Furuichi

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Takahiro Ochiya

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Shuichi Kaneko

13

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

language of work or name

0 references

publication date

5 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

43

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

2956-2968

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Human adipose tissue is a source of multipotent stem cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Stem cells in the treatment of heart disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Primary biliary cirrhosis: an orchestrated immune response against epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Autoimmune Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Inflammation and fibrogenesis in steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Pathology of immune-mediated liver injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

The 1.2 A resolution structure of the Con A-dimannose complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

The role of myeloid cells in the promotion of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Importance of Kupffer cells for T-cell-dependent liver injury in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

CXCR4-CCR5: a couple modulating T cell functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

21 January 2018

Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of IL-10, an anti-inflammatory cytokine in murine liver injury induced by Concanavalin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of an extrathymic T-cell development pathway by oncostatin M

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343531

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201343531

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

release_cqdfulgtzvdavmzud47qxxtrl4

1 reference

https://api.fatcat.wiki/v0/release/cqdfulgtzvdavmzud47qxxtrl4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/23934743

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47806980&oldid=2171570825"